Regenerative orthopedic clinic diagnostic
A precise view of where qualified patient intent slows before the consult.
They assume you sell injections to people with knee pain. You don't. You sell a decision to people who have already been handed a worse one.
By the time a patient finds you, an orthopedic surgeon has usually already told them one of three things, and they can quote it back word for word: you're bone on bone, there's nothing left to do except replace it. Or come back when it's worse. Or you'll need surgery eventually, might as well do it now. That sentence is why they're searching. It's the opening line of every consult you run, whether the patient says it out loud or not.
So they arrive carrying a number. A knee replacement runs $35,000 to $50,000 all in, three to six months before full activity, and a quiet fear the replacement could leave them worse than the joint they started with. Against that,
A $4,000 to $6,000 biologic isn't the expensive option. It's the rescue.
Your patients run this math themselves, unprompted, before anyone at your front desk says a word. One put it in a sentence: fortunately, there was another option. She framed surgery as the misfortune and your procedure as the way out, on her own.
Which means your real problem was never demand, and never price. The patient already wants what you offer and has already justified the cost. Your problem is the gap between wanting it and trusting it, and in your field that gap is wider and meaner than in any other cash-pay specialty in medicine.
Here's what sits in it.
Most of your patients arrive post-cortisone. Two shots, three, sometimes five. The first ones worked for a few months, then stopped, and many of them learned along the way that the steroid they kept going back for may have been quietly degrading the cartilage they were trying to save. So they don't arrive curious. They arrive burned by the last thing a doctor promised would help, primed to assume you're the next one.
They also arrive suspicious of the whole category, and not without reason. They've seen the free-steak-dinner seminars selling $15,000 packages. They've read the headlines about blindness and unregulated products. A widely-cited study found 96 percent of stem cell clinic websites contained at least one false or misleading claim, averaging four to five each, and your prospective patient has absorbed that reporting even if they can't name the source. So when they sit across from you, a fellowship-trained, board-certified physician running rigorous protocols, they're looking at you through a lens smeared by every bad actor who ever called themselves a stem cell clinic. You inherit the category's reputation before you say a word. The phrases surface in nearly every consult: is this just snake oil. my doctor said it doesn't work. is there actual evidence for this.
That's where you are. Selling a genuinely good decision to a patient who's already made the math work, already been failed by the previous treatment, and already been taught, by the media and by your worst competitors, to assume you're a fraud. The whole game is trust. And almost nothing in your current marketing is built to win it before the patient is already in the room deciding.
If the math already favors you and the patient already wants the outcome, then every lost patient is a trust failure, not a demand failure. So the real question is narrow: where is the trust leaking out? Four places. None of them where your last agency told you to look.
Your patient is often in real pain, researching at eleven at night, filling out a form in a moment of resolve. The clinic that reaches them inside five minutes wins roughly four out of five of those patients. The industry average response time is measured in dozens of hours. Every hour of silence is an hour they spend talking themselves back into doubt, or calling the next clinic on the list. The lead was never the problem. The silence after it was.
The first human a nervous, skeptical, post-cortisone patient talks to is almost always the least-trained role in your practice for the conversation that actually matters. This patient doesn't want a scheduler. They want someone who can hold a science-adjacent conversation without flinching. Ask is there evidence for this and get transferred, or handed a brochure, or met with a pause, and the trust window shuts in that instant. Your most important sales conversation is happening at the lowest-paid seat in the building, and no one trained for it.
The consult goes well. Good questions, real engagement, then the words you've heard a thousand times: let me go home and think about it. For a cash-pay decision above $4,000, that window runs one to three months, and a patient who walks out without a structured way to stay in contact doesn't come back on their own. They don't book elsewhere out of preference. They drift. And the most-researched, most-qualified patients drift longest, because thinking is what they do.
Google bans direct promotion of these procedures, and Meta has conversion tracking disabled for most regenerative clinics. So the ad that actually started a patient's journey ran sixty to ninety days before they called, and by the time they book, the whole thing reads as organic. You're flying with the instruments taped over. You feel that some months are good and some are lean, but you can't trace a single patient back to what produced them, which means you can't confidently spend more on what works or kill what doesn't. The feast-or-famine isn't bad luck. It's the predictable result of running acquisition with no attribution, in a category that structurally denies it to you.
The consultation is your product.
Underneath all four is one structural truth, and it's the one your field punishes hardest: the consultation is your product. Across every study of what converts these patients, the deciding factor is never the brochure, the ad, or the price. It's whether one clinical conversation made them feel seen, met at their level of research, and told honestly what this will and won't do for their specific grade of joint. The patients who book got that conversation. The ones who ghost needed it and got a sales pitch, a brochure, or silence instead.
So here's why it's happening, plainly. You have exactly one thing that reliably converts a skeptical, surgery-facing, cortisone-burned patient: a real clinical conversation that earns their trust. And you can only deliver it one patient at a time, by hand, in a consult room, after they've survived the slow call-back, the untrained front desk, and the silent nurture gap. So most of them never reach the one thing that would have closed them. Your best asset is locked at the bottom of a funnel most patients fall out of before they get there.
That's the problem worth fixing. Not more leads into a funnel that leaks trust at four seams. The conversation that already works, delivered to many qualified patients at once, before the call.
We are not going to hold anything back here. By the end of this section you will understand the entire Patient Rhythm Method well enough to diagram it on a napkin. That is deliberate. A method you can see all the way through is one you can trust, and trust is the only currency that matters with the patient you are trying to reach. The Method has three beats: Signal, Session, Sequence. Each one fixes a specific leak from the section you just read.
Signal is how the right patient finds you and the wrong patient screens themselves out before they ever cost you a consult.
Your current advertising, if it runs at all, is built to generate leads. That is the wrong target. Lead volume was never your constraint, and the insurance-seekers, price-shoppers, and Grade 4 bone-on-bone non-candidates who answer a generic knee-pain ad are the exact people who waste your consult hours and never book. More of them is not progress. It is more expensive failure.
Signal does the opposite. It speaks only to the patient who has already been to the orthopedic surgeon, already heard the replacement conversation, and is actively searching for the thing you do. The message names that patient's exact moment back to them: the surgeon who said bone-on-bone, the cortisone that stopped working, the surgery they are trying to avoid. A patient who is not in that moment scrolls past. A patient who is in that moment feels recognized, which is the first quiet deposit of trust before they have even clicked.
The mechanics matter more in your field than in any other, because of the constraint you live under. Google bans direct promotion of these procedures. Meta has conversion tracking disabled for most regenerative clinics and restricts the language you are allowed to use. So Signal is built to run inside those rails, not against them: awareness-led creative that leads with the patient's problem and the surgery-alternative frame, never with a banned efficacy claim, never with a before-and-after that reclassifies your procedure as an unapproved drug. The same FDA posture that sent over four hundred warning letters to clinics in this space is the posture Signal is engineered around. Most agencies either get your ad account shut down or get you a warning letter. Signal is built by people who know which words trigger which agency.
The point of Signal is not a flood of leads. It is a smaller, cleaner stream of the exact patient your Session was built to convert.
Session is the heart of the Method, and it is the direct fix for the truth at the bottom of the last section: the consultation is your product, and right now it is locked at the bottom of a funnel most patients never reach.
The Session is a live training you present once a month, about sixty minutes, to a room of these pre-qualified patients at once. It is the clinical conversation that closes them, delivered to thirty or fifty or a hundred people simultaneously, before any of them has called your front desk. You are not selling on it. You are teaching, in exactly the way that makes a skeptical patient lower their guard. Here is the full arc, beat by beat.
It opens by naming their moment, not your credentials. The first few minutes are not about you. They are about the patient who was told bone-on-bone, who exhausted cortisone, who is staring down a $40,000 surgery and six months of recovery and is not ready to accept it. When a patient hears their own situation described more precisely than they could describe it themselves, they conclude the person describing it understands their problem. That conclusion buys you the next fifty minutes.
It names the enemy, and the enemy is not the patient's surgeon. This is the most delicate move in the entire Session and the one most clinics get wrong. The patient walks in with their surgeon's voice in their head saying this does not work. If you attack that surgeon, you attack the patient's own judgment for having trusted him, and you lose. So the Session validates the surgeon's conservatism, then reframes: your surgeon is right that this is not guaranteed, and surgery is not guaranteed either. Here is what the evidence actually shows for your specific grade of joint. The enemy is the false certainty that surgery is the only path, not the surgeon who offered it.
It teaches the mechanism in plain, peer-level language. This patient has watched the YouTube explainers and read the abstracts they could half-parse. Talk down to them with your body wants to heal itself and you insult them. The Session explains what PRP and BMAC actually are, what they target, and why this is a different category of intervention than the cortisone that failed them. The cortisone point lands hard here, because many of them suspect the steroid was degrading the cartilage and no one ever confirmed it. When you do, you become the first person who told them the truth.
It confronts the skepticism wall directly, by raising the objections before they can. The Session names the free-dinner seminars, the $15,000 hotel-ballroom packages, the headlines, the ninety-six percent of clinic websites found to carry false claims. It says out loud: this category has earned its bad reputation, here is how you tell a rigorous clinic from a mill, here are the questions you should ask anyone before you let them inject you. A clinic willing to hand the patient the tools to screen out bad actors, including itself, is a clinic the patient stops suspecting.
It defines candidacy honestly, including who this will not help. The Session states plainly that this works best for certain grades of joint and that a Grade 4 bone-on-bone patient may genuinely be better served by surgery. This costs you nothing, because that patient was never going to get a good outcome anyway, and it buys enormous credibility with everyone else in the room, who now believes every yes because they have heard you say no.
It frames outcomes the way believable people frame them. Not pain free, not cure, not regrows cartilage, which is both an overclaim and the exact language that triggers an FDA letter. The Session speaks in the register of the patient who says I am ninety percent improved and back to climbing ladders. Realistic, specific, his-life outcomes. Believable results convert the skeptic that miracle claims repel.
It closes not with a hard pitch, but with a single next step. The Session does not demand a decision on a $6,000 procedure in front of a hundred people. It ends by offering the one thing that patient has wanted the whole time and never been given: a real conversation about their specific case, their specific imaging, their specific joint. The close is an invitation to be seen, which for this patient is irresistible, because being unseen by conventional medicine is the wound that started their search.
That is the full Session. It is your best consultation, the one that already converts, rebuilt so it can be delivered to a room instead of one chair at a time, and engineered to survive the skepticism, the surgeon's shadow, and the compliance rails that define your field.
Sequence is the fix for the leak that costs you the most patients and that you can see the least: the 30-to-90-day fog.
The most-researched, most-qualified patients are exactly the ones who say let me think about it and then drift, because thinking is what they do, and the cash-pay consideration window for a decision above $4,000 runs one to three months. A patient who leaves without a structured way to stay in contact does not come back on their own. Right now that patient is simply lost, and you have no way to even know it happened.
Sequence is the follow-up system that keeps the conversation alive across that entire window. It is not reminder emails. It is a structured continuation of the Session's teaching: the answer to the next objection the patient was always going to raise, the patient story that matches their exact injury, the evidence on their specific grade of joint, the gentle restatement of the surgery-alternative math, spaced across the weeks it actually takes them to decide. It meets the chronic researcher with more of the thing they crave, which is information, until the deliberation resolves in your favor instead of in silence.
Signal brings the right patient. The Session pre-sells them at scale. The Sequence catches the ones who need more time so they convert instead of evaporating. Run it monthly, and the next month's room is filling before this month's has emptied. That is the rhythm the name promises, and that is a calendar that stops swinging.
You now have the whole Method. Signal, Session, Sequence, named and explained, with the full arc of the Session laid out beat by beat. You could draw it. You understand it completely, which was the point, because a method you cannot see is a method you cannot trust.
Here is the honest part, and it is the part a surgeon understands faster than anyone.
Knowing the structure of a procedure and being able to perform it are not the same thing.
You could hand a smart person the steps of an arthroscopy and they still could not do the surgery, because the structure is the small part and the thousand reps of judgment under live conditions are the rest. The Session is the same. Knowing its arc is one afternoon. Building one that holds a skeptical room, names the objections in the right order, stays inside the compliance rails so it never costs you a warning letter, gets the surgeon-reframe exactly right, and then runs every single month while you also run a clinic, is a different thing entirely. That gap is not information. It is execution, and execution is months of reps you do not have the time to spend.
That is the whole reason we exist. You teach the sixty-minute Session, the part only the credible physician in the room can do. We build and run everything else: the Signal that fills the room inside your field's rails, the Session structure and funnel, and the Sequence that catches the deliberators. You bring the medicine and the credibility. We bring the rhythm.
The next page shows you what one Session a month could mean in your own numbers.
What follows is not a promise. It is not a projection of what Cadence will produce for you. It is arithmetic, run with your own numbers and deliberately conservative assumptions, so you can see the shape of what one Session a month means before you ever decide to work with anyone. We will show you how to run it, and then you run it yourself, because a number you calculate is one you believe and a number we hand you is one you discount. That is exactly as it should be.
We did not fill in the final figure for you on purpose. Anyone who hands a brand-new relationship a precise dollar projection it cannot yet verify is doing the exact thing this document was written against. Set every assumption low, then bring this math to the training, where we walk through it live with the real mechanics behind each step. Results vary by market, by specialty, by pricing, and by execution, and no two clinics run the same. This is a way to think, not a thing we are guaranteeing.
You have read the diagnosis. You have seen the Method, the full arc of the Session, and the math. The training is where it stops being a document and becomes a conversation you are part of, with the mechanics behind every step laid open and your questions answered live. Come with these three things. Not to prepare for a pitch, but because the owners who get the most out of the training arrive with their own situation already in focus.
Not an estimate, the actual one. On the training we run the math live, and the entire model bends on this single figure. When we get to your numbers, you want yours in hand, because a Session-warmed patient tends to convert higher than a cold consult, and seeing your own rate move under that assumption is the moment the whole thing stops being theory.
You know the one. The qualified patient who sat in your consult, asked good questions, then drifted into the 30-to-90-day fog and never came back. Hold that specific patient in mind, because the part of the training that covers the Sequence is built precisely for them, and watching the system catch the patient you actually lost is more convincing than any slide.
Snake oil. My surgeon said it doesn't work. Is there evidence. Whatever lands in your consult room most often and costs you the most patients. On the training we show exactly where in the Session that objection gets disarmed, before the patient can raise it, and you will want to test it against the one you fight hardest.
This is live, once, about sixty minutes, and the part that matters most is the part that cannot be recorded: the questions. We keep the room small so the Q and A stays real, which means there is room to put your specific clinic, your specific bottleneck, your specific numbers in front of us and get a straight answer. A replay can hand you the structure. It cannot answer the question only you were going to ask. If you can be there live, be there live.
That is everything you need. The diagnosis is in your hands. The Method is laid out in full. The only thing left is the room, and your seat is already saved.
We will see you on the training.